by GlobeNewsWire | Jan 11, 2016 | Globe Newswire, GNW Alerts
WEST ORANGE, N.J., Jan. 11, 2016 (GLOBE NEWSWIRE) — Kessler Foundation awarded $2,309,230 million in grants to organizations across the U.S. to support initiatives that create or expand job training and employment initiatives for people with disabilities. Since...
by GlobeNewsWire | Jan 11, 2016 | Globe Newswire, GNW Alerts
WEST ORANGE, N.J., Jan. 11, 2016 (GLOBE NEWSWIRE) — Kessler Foundation awarded a two-year, $282,000 grant to Supported Employment Enterprise Corporation (SEEC) to launch the “Maryland Customized Employment Project”—an initiative to improve employment...
by GlobeNewsWire | Jan 11, 2016 | Globe Newswire, GNW Alerts
WEST ORANGE, N.J., Jan. 11, 2016 (GLOBE NEWSWIRE) — Kessler Foundation awarded a two-year, $400,762 grant to the Mercy Health Foundation to develop and implement a Healthcare Workforce Inclusion Model in St. Louis, Missouri, in an effort to improve employment...
by GlobeNewsWire | Jan 11, 2016 | Globe Newswire, GNW Alerts
WEST ORANGE, N.J., Jan. 11, 2016 (GLOBE NEWSWIRE) — Kessler Foundation awarded a two-year, $407,468 grant to the Florida Atlantic University (FAU) Foundation to start Bridging the Gap from College to Careers (C2C)—an initiative to help college students...
by GlobeNewsWire | Jan 11, 2016 | Globe Newswire, GNW Alerts
SAN RAFAEL, Calif., Jan. 11, 2016 (GLOBE NEWSWIRE) — BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced interim results from INSPIRE, a Phase 2 trial for reveglucosidase alfa, a fusion protein of insulin-like growth factor 2 and acid alpha-glucosidase...